Obermatt
See Similar Stocks →

Lexeo Therapeutics

NMQ:LXEO · US52886X1072
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings42
Price/Book60
Dividend Yield—
Revenue Growth—
Profit Growth61
Capital Growth40
TSR 52w30
Leverage63
Liquidity7
Refinancing49
Combined—
Analyst Opinions63
Pro Holdings77
Opinion Changes14
Market Pulse81

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2017
Employees95
Websitelexeotx.com
ISINUS52886X1072
Last UpdateApr 2, 2026
Index & Theme
GeneticsCardiovascularNeurologyCentral Nervous SystemGenetic DisorderBiotechnologyLife ScienceTherapeutics

Description

Lexeo Therapeutics, Inc. (Lexeo) operates as a clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular diseases are treated. The company advances a portfol…

Similar Stocks

The companies this stock is ranked against.

Compare Lexeo Therapeutics with its peers
MeiraGTx
NSQ:MGTX
18
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Tenaya Therapeutics
NSQ:TNYA
29
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Rocket Pharmaceuticals
NMQ:RCKT
31
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
PMV Pharmaceuticals
NSQ:PMVP
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Mineralys Therapeutics
NSQ:MLYS
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Vir Biotechnology
NSQ:VIR
56
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →